These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9230641)

  • 1. Neuroendocrine effects of electroconvulsive therapy (ECT).
    Swartz CM
    Psychopharmacol Bull; 1997; 33(2):265-71. PubMed ID: 9230641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine testing in electroconvulsive therapy.
    Kamil R; Joffe RT
    Psychiatr Clin North Am; 1991 Dec; 14(4):961-70. PubMed ID: 1771157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute neurohumoral response to electroconvulsive therapy during pregnancy. A case report.
    Griffiths EJ; Lorenz RP; Baxter S; Talon NS
    J Reprod Med; 1989 Nov; 34(11):907-11. PubMed ID: 2573726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
    Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
    Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TPS vs propofol in electroshock therapy: neuroendocrine changes].
    Biancofiore G; Lenzi A; Sansevero A; Burchi F
    Minerva Anestesiol; 1991 Sep; 57(9):634-5. PubMed ID: 1665900
    [No Abstract]   [Full Text] [Related]  

  • 6. Electroconvulsive therapy's mechanism of action: neuroendocrine hypotheses.
    Haskett RF
    J ECT; 2014 Jun; 30(2):107-10. PubMed ID: 24800689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome.
    Deakin JF; Ferrier IN; Crow TJ; Johnstone EC; Lawler P
    Br J Psychiatry; 1983 Dec; 143():618-24. PubMed ID: 6661605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine hypothesis of antidepressant action of ECT.
    Fink M
    Psychopharmacol Bull; 1988; 24(3):400-2. PubMed ID: 3153500
    [No Abstract]   [Full Text] [Related]  

  • 9. Electroconvulsive therapy-induced cortisol release after dexamethasone in depression.
    Swartz CM
    Neuropsychobiology; 1992; 25(3):130-3. PubMed ID: 1407478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the prolactin response induced by electroconvulsive therapy in schizophrenics.
    Arató M; Erdós A; Kurcz M; Vermes I; Fekete M
    Acta Psychiatr Scand; 1980 Mar; 61(3):239-44. PubMed ID: 7376927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder].
    Ozsoy S; Eşel E; Hacimusalar Y; Candan Z; Kula M; Turan T
    Turk Psikiyatri Derg; 2008; 19(4):341-8. PubMed ID: 19110975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Total Amount of Prolactin Released by Electroconvulsive Therapy.
    Swartz CM
    Convuls Ther; 1985; 1(4):252-257. PubMed ID: 11940830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Stimulus Energy on Electroconvulsive Therapy-Induced Prolactin Release.
    Zis AP; McGarvey KA; Clark CM; Lam RW; Patrick L; Adams SA
    Convuls Ther; 1993; 9(1):23-27. PubMed ID: 11941188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive Therapy-Induced Prolactin Release as an Epiphenomenon.
    Swartz CM
    Convuls Ther; 1991; 7(2):85-91. PubMed ID: 11941107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical properties and quantification of the ECT stimulus: I. Basic principles.
    Sackeim HA; Long J; Luber B; Moeller JR; Prohovnik I; Devanand DP; Nobler MS
    Convuls Ther; 1994 Jun; 10(2):93-123. PubMed ID: 8069647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forebrain pathways mediating stress-induced hormone secretion.
    Van de Kar LD; Blair ML
    Front Neuroendocrinol; 1999 Jan; 20(1):1-48. PubMed ID: 9882535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse and recurrence following a course of ECT: reasons for concern and strategies for further investigation.
    Grunhaus L; Dolberg O; Lustig M
    J Psychiatr Res; 1995; 29(3):165-72. PubMed ID: 7473293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECT treatment does not enhance neuroendocrine responses to serotonergic challenge.
    Manji HK; Hsiao JK; Risby ED; Osman OT; Rudorfer MV; Potter WZ
    J Psychopharmacol; 1992 Jan; 6(4):501-8. PubMed ID: 22291398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stimulus intensity on the efficacy and safety of twice-weekly, bilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised controlled trial.
    Mohan TS; Tharyan P; Alexander J; Raveendran NS
    Bipolar Disord; 2009 Mar; 11(2):126-34. PubMed ID: 19267695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.